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Abstract
Introduction:  Changes  in  carbohydrate  metabolism  may  lead  to  recurrence  of  benign  paroxys-
mal positional  vertigo.
Objective:  To  evaluate  the  inﬂuence  of  the  disturbance  of  carbohydrate  metabolism  in  the
recurrence  of  idiopathic  BPPV.
Methods:  A  longitudinal  prospective  study  of  a  cohort,  with  41  months  follow-up.  We  analyzed
the results  of  72  glucose--insulin  curves  in  patients  with  recurrence  of  BPPV.  The  curves  were
classiﬁed into  intolerance,  hyperinsulinemia,  hyperglycemia  and  normal.
Results: The  RR  for  hyperinsulinism  was  4.66  and  p  =  0.0015.  Existing  hyperglycemia  showed
an RR  =  2.47,  with  p  =  0.0123.  Glucose  intolerance  had  a  RR  of  0.63,  with  p  =  0.096.  When  the
examination  was  within  normal  limits,  the  result  was  RR  =  0.2225  and  p  =  0.030.
Discussion:  Metabolic  changes  can  cause  dizziness  and  vertigo  and  are  very  common  in  people
who have  cochleovestibular  disorders.  However,  few  studies  discuss  the  relationship  between
idiopathic  BPPV  and  alterations  in  carbohydrate  metabolism.  In  the  present  study,  we  found  that
both hyperglycemia  and  hyperinsulinemia  are  risk  factors  for  the  recurrence  of  BPPV,  whereas  a
normal test  was  considered  a  protective  factor;  all  these  were  statistically  signiﬁcant.  Glucose
intolerance  that  was  already  present  was  not  statistically  signiﬁcant  in  the  group  evaluated.
 Please cite this article as: Webster G, Sens PM, Salmito MC, Cavalcante JD, dos Santos PR, da Silva AL, et al. Hyperinsulinemia and
hyperglycemia: risk factors for recurrence of benign paroxysmal positional vertigo. Braz J Otorhinolaryngol. 2015;81:347--51.
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Conclusion:  Hyperinsulinemia  and  hyperglycemia  are  risk  factors  for  the  recurrence  of  idio-
pathic BPPV  and  a  normal  exam  is  considered  a  protective  factor.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Hiperinsulinismo  e  hiperglicemia:  fatores  de  risco  para  recorrência  de  vertigem
postural  paroxística  benigna
Resumo
Introduc¸ão: As  alterac¸ões  do  metabolismo  do  carboidrato  podem  levar  a  recorrência  de  ver-
tigem posicional  paroxística  benigna.
Objetivo:  Avaliar  a  inﬂuência  dos  distúrbios  do  carboidrato  na  recorrência  da  VPPB  idiopática.
Método:  Estudo  longitudinal,  do  tipo  coorte,  prospectivo,  com  41  meses  de  acompanhamento.
Analisaram-se  72  resultados  de  curvas  glicoinsulinêmicas  em  pacientes  portadores  de  recorrên-
cia de  VPPB.  As  curvas  foram  classiﬁcadas  em  intolerância,  hiperinsulinemia,  hiperglicemia  e
normal.
Resultados:  O  hiperinsulinismo  teve  RR  =  4,66  e  p  =  0,0015.  A  hiperglicemia  apresentou  um
RR =  2,47  e  p  =  0,0123.  Na  intolerância  a  glicose  o  RR  =  0,63  e  p  =  0,096.  No  exame  normal,  o
RR =  0,2225  e  p  =  0,030.
Discussão:  As  alterac¸ões  metabólicas  podem  causar  tontura  e  vertigem  e  são  muito  frequentes
na populac¸ão  que  apresenta  distúrbios  cocleovestibulares.  Contudo,  poucos  trabalhos  falam
sobre a  relac¸ão  entre  a  VPPB  idiopática  e  as  alterac¸ões  nos  carboidratos.  No  presente  estudo,
veriﬁcou-se  que  tanto  a  hiperglicemia,  quanto  o  hiperinsulinismo  são  fatores  de  risco  para
recorrência  de  VPPB,  ao  passo  que  o  exame  normal  foi  considerado  fator  protetor,  todos  estes
estatisticamente  signiﬁcantes.  Já  a  intolerância  à  glicose  não  teve  signiﬁcância  estatística  no
grupo avaliado.
Conclusão:  O  hiperinsulinismo  e  a  hiperglicemia  se  comportam  como  fatores  de  risco  para  a
recorrência  de  VPPB  idiopática,  assim  como  o  exame  normal  como  um  fator  protetor.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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enign  postural  (or  positional)  paroxysmal  vertigo  (BPPV)  is
he  most  common  cause  of  dizziness  in  the  adult  population,
nd  is  classiﬁed  as  a  peripheral  vestibular  syndrome.1--3 BPPV
redominates  in  females  and  in  those  aged  greater  than
0--60  years.  In  addition,  approximately  30%  of  the  elderly
ged  over  70  years  will  experience  at  least  one  episode  of
PPV  in  their  lives.4,5
In  most  cases,  the  patient  suffers  from  idiopathic  BPPV.
n  secondary  BPPV,  some  causes  have  been  found,  such  as:
raumatic  brain  injury,  post-operative  ear  surgery,  verte-
robasilar  insufﬁciency,  vestibular  neuronitis  and  Ménière’s
isease.6 However,  few  studies  have  related  metabolic
hanges  with  BPPV,  or  even  identiﬁed  such  changes  as  a
ause  of  secondary  BPPV.7
Numerous  metabolic  disorders  can  affect  the
ochleovestibular  apparatus.8--12 Changes  in  carbohy-
rate  metabolism,  more  precisely  in  glucose  metabolism,
ave  been  associated  with  frequent  causes  of  inner  ear
isorders.8--12In  carbohydrate  disorders,  especially  those  affecting
lucose,  some  authors  propose  that,  in  patients  with  chroni-
ally  hyperglycemic  diabetes  mellitus,  the  histopathological
o
Bhanges  of  microangiopathy  and  peripheral  neuropathy  are
resent.11,13 Considering  that  the  inner  ear  receives  vascu-
arization  through  terminal  branches,  such  changes  might
ompromise  vestibular  function,  due  to  a  decreased  blood
upply  to  this  organ.
The  post-mortem  study  of  temporal  bones  performed  by
oda  et  al.10 found  that  patients  with  type  1  diabetes  mel-
itus  exhibit  a  much  higher  prevalence  of  otocone  debris
oming  from  the  utricle,  compared  to  healthy  patients.  In
ddition,  these  authors  found  that  the  prevalence  of  migra-
ion  of  such  debris  also  was  increased,  in  proportion  to  the
ears  of  illness.  Thus,  there  is  a  greater  chance  of  BPPV
n  patients  with  type  1  diabetes  mellitus.  Cohen  et  al.14
bserved  a  20%  prevalence  of  diabetes  mellitus  in  patients
ith  BPPV  aged  between  65  and  74  years,  and  a  43%  preva-
ence  in  people  over  75  years.
In  the  literature,  recurrence  of  BPPV  varies  between  20%
nd  30%.1,15 Several  factors  have  been  linked  to  the  devel-
pment  of  recurrence,  including  age,  gender,  and  etiology
f  BPPV.1,15 However,  it  still  remains  uncertain  whether  or
ot  there  is  a  correlation  with  metabolic  disorders.
The  aim  of  this  study  was  to  evaluate  the  inﬂuence
f  carbohydrate  disorders  in  the  recurrence  of  idiopathic
PPV.
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(Fig.  3),  RR  =  4.6647,  p  =  0.0015.
•  With  a  result  of  hyperglycemia  in  glucose--insulin  tests
(Fig.  4),  RR  =  2.4761,  p  =  0.0123.
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Methods
This  study  was  approved  by  the  Ethics  Committee  of  the
hospital  where  it  was  conducted,  according  to  CAEE  protocol
number  06181512.2.0000.5442.
This  is  a  longitudinal  cohort  study,  which  evaluated  medi-
cal  records  of  patients  with  an  objective  diagnosis  of  benign
paroxysmal  positional  vertigo  established  by  the  otoneurol-
ogy  outpatient  clinic  of  the  Otolaryngology  Department  of  a
tertiary  hospital  during  the  period  from  December  2009  to
May  2013.  This  diagnosis  was  reviewed  more  than  once  in
those  cases  where  recurrence  of  the  disease  occurred.
Patients  with  objective  idiopathic  benign  paroxysmal
positional  vertigo  monitored  in  the  otoneurology  outpatient
clinic  until  their  discharge  (which  occurred  only  after  an
asymptomatic  period  of  6  months),  and  who  submitted  to  a
requested  3-h  glucose  tolerance  test  were  included.
Patients  with  subjective  benign  paroxysmal  positional
vertigo  or  with  other  causes  of  dizziness  not  associated  with
BPPV,  as  well  as  patients  who  discontinued  or  were  lost
to  follow-up  before  discharge,  those  failing  to  make  the
required  tests,  or  patients  with  a  previous  diagnosis  and
treatment  for  BPPV  were  excluded.  Patients  diagnosed  with
secondary  BPPV  of  undetermined  etiology,  such  as  traumatic
brain  injury,  Ménière’s  disease,  vestibular  neuronitis,  post-
operative  of  ear  surgery,  and  vertebrobasilar  insufﬁciency
were  also  excluded.
All  clinical  records  of  patients  with  a  diagnosis  of  BPPV
registered  at  the  otoneurology  outpatient  clinic,  Depart-
ment  of  Otolaryngology,  were  surveyed.  In  these  charts,  we
collected  the  relevant  data  at  diagnosis.
A  survey  of  the  records  of  all  patients  who  had  a  diag-
nosis  of  BPPV  registered  at  the  otoneurology  outpatient
clinic,  Otolaryngology  Department,  was  conducted.  In  these
clinical  records,  all  data  were  obtained  at  the  date  of
diagnosis.
Recurrence  of  the  disease  was  evaluated  both  qualita-
tively  and  quantitatively;  ‘‘recurrence’’  was  deﬁned  as  that
clinical  picture  in  which  disappearance  of  vertigo  and  posi-
tional  nystagmus  occurred  after  repositioning  maneuvers
(RM),  with  assessment  by  Dix-Hallpike  maneuver  and  roll
test,  but  with  return  of  these  signs  and  symptoms  veriﬁed
by  an  ENT  physician  within  six  months  of  follow-up.  After
RM  repetition,  these  patients  were  again  asymptomatic.
Finally,  patients  whose  nystagmus  and  vertigo  did  not  disap-
pear  when  RM  were  carried  out  under  the  supervision  of  an
otolaryngologist  were  classiﬁed  as  having  persistent  BPPV.
It  must  be  emphasized  that  the  recurrences  of  episodes  of
BPPV  were  evaluated  through  anamnesis  and  also  by  Dix-
Hallpike  maneuver  and  roll  test.
The  results  of  the  glycemic  curve  test  were  analyzed
and  classiﬁed  according  to  American  Diabetes  Association
(ADA)  criteria  published  in  2013,  and  the  interpretation  of
the  insulinemic  curve  was  based  on  those  criteria  proposed
by  Kraft  (1975).14,15 Therefore,  our  patients  were  classiﬁed
into  four  groups,  according  to  the  results  of  their  glucose-
insulin  curves:  patients  with  a  normal  test,  patients  with
impaired  glucose  tolerance  (who,  according  to  ADA,  are
called  pre-diabetic  patients),  patients  with  hyperinsulinism,
and  patients  with  hyperglycemia  (who,  according  to  ADA,
are  called  diabetics);  in  these  patients,  the  relationship  with
the  recurrence  of  BPPV  was  evaluated.
F
rigure  1  Distribution  of  patients  with  BPPV  recurrence,
egarding  glucose--insulin  tests  within  normal  limits.
The  Chi-squared  test  was  used  to  assess  quantita-
ively  the  relationship  between  changes  in  carbohydrate
etabolism  and  rate  of  recurrence.  The  statistical  signiﬁ-
ance  level  was  set  at  p  =  0.05.
esults
n  this  study,  103  medical  records  of  patients  with  benign
aroxysmal  positional  vertigo  during  the  period  from  Decem-
er  2009  to  May  31,  2013  were  evaluated.  Of  these,  31
atients  were  excluded  from  the  study  (11  patients  for  hav-
ng  subjective  BPPV;  5  patients  whose  medical  records  were
ot  found  in  the  hospital  medical  ﬁle;  7  patients  for  not  hav-
ng  performed  the  required  tests  and/or  for  discontinuation
f  clinical  follow-up;  and  8  patients  for  not  being  considered
s  idiopathic  cases).  Thus,  the  ﬁnal  number  of  cases  was  72
atients,  whose  sample  was  divided  as  follows:
 With  a  normal  result  in  glucose--insulin  tests  (Fig.  1),  a
relative  risk  (RR)  of  0.2225  was  found,  with  p  =  0.03054.
 With  a  result  of  impaired  glucose  tolerance  in
glucose--insulin  tests  (Fig.  2),  RR  =  0.6315,  p  =  0.096.
 With  a  result  of  hyperinsulinemia  in  glucose--insulin  testsigure  2  Distribution  of  patients  with  BPPV  recurrence,
egarding  tests  with  glucose  intolerance.
350  
Hyperinsulinemia
No recurrence 
0.00%
43.06%
20.83%
11.11%
25.00%
20.00%
40.00%
60.00%
No recurrence 
Recurrent 
Recurrent 
Abnormal test Abnormal test 
Abnormal test 
Normal test
Normal test
Normal test
Figure  3  Distribution  of  patients  with  BPPV  recurrence,
regarding  tests  with  hyperinsulinemia.
Hyperglicemia
No recurrence 
No recurrence 
Recurrent 
Recurrent 
Normal test
Normal test
Normal test
Abnormal test Abnormal test 
Abnormal test 
54.17%
9.72%
0.00%
20.00%
40.00%
60.00%
25.00%
11.11%
F
r
D
D
e
a
i
e
v
A
f
e
p
t
i
a
d
c
B
e
p
a
r
l
a
a
d
w
r
m
m
w
p
g
c
t
l
p
s
s
n
s
m
p
t
t
e
t
B
h
a
t
r
r
C
t
h
s
h
r
r
w
s
i
s
C
G
r
b
t
g
C
T
Rigure  4  Distribution  of  patients  with  BPPV  recurrence,
egarding  tests  with  hyperglycemia.
iscussion
izziness  is  a  major  limiting  factor  in  the  daily  life  of  the  gen-
ral  population,  with  exacerbation  in  the  elderly  because  it
ffects  movements  of  those  who  experience  it,  and  it  can
nterfere  with  domestic  and  even  social  activities.16 The
lderly  lose  their  autonomy  and  become  dependent  indi-
iduals,  which  further  decreases  their  quality  of  life.17--20
n  important  consequence  of  dizziness  is  the  occurrence  of
alls,  especially  for  those  over  60  years  of  age,  because  the
ffects  are  even  more  severe.4 In  Brazil,  6802  elderly  peo-
le  died  from  falls  in  the  year  201021 --  an  alarming  fact  in
erms  of  public  health.  This  can  be  partly  explained  by  BPPV
n  the  elderly.4
Although  benign  paroxysmal  positional  vertigo  has  been
 recognized  entity  for  decades,  its  etiology  remains  pre-
ominantly  idiopathic.6,22,23 However,  few  studies  have  been
onducted  with  the  aim  to  clarify  the  relationship  between
PPV  and  other  comorbidities,  and  how  they  could  inﬂu-
nce  the  disease  severity  and  the  prognosis  of  these  clinical
ictures.
There  is  good  evidence  that  metabolic  disorders  can  be
ssociated  with  BPPV7--12 but  it  is  difﬁcult  to  conﬁrm  a  causal
elationship,  since  it  is  impossible  to  observe  the  histopatho-
ogical  changes  in  vivo. These  metabolic  disorders  can  act
s  a  principal  etiological  factor  in  vestibular  dysfunction,
s  well  as  an  aggravating  factor  of  a  pre-existing  vestibular
isorder.9We  did  not  ﬁnd  statistical  signiﬁcance  for  patients
ith  glucose  intolerance  in  relation  to  the  number  of
ecurrences,  compared  to  normal  subjects.  This  ﬁnding
ay  suggest  that  this  degree  of  change  in  carbohydrateWebster  G  et  al.
etabolism  is  not  signiﬁcant  to  the  point  of  an  association
ith  the  evolution  of  BPPV.  However,  no  theories  can  be
roposed  until  a larger  number  of  patients  with  impaired
lucose  tolerance  and  also  with  BPPV  have  been  evaluated.
On  the  other  hand,  the  presence  of  hyperinsulinism
an  negatively  impact  inner  ear  hemostasis,  as  a result  of
he  ionic  and  metabolic  characteristics  of  the  stria  vascu-
aris,  which  is  responsible  for  maintaining  the  endocochlear
otential  through  potassium  secretion  into  endolymphatic
pace.8,9 Furthermore,  the  labyrinth  is  very  sensitive  to
mall  changes  in  plasma  insulin  levels,  due  to  the  large
umber  of  insulin  receptors  present  in  the  endolymphatic
ac.11
Based  on  these  suggestive  signs  (i.e., that  glucose
etabolism  may  be  associated  to  clinical  pictures  of  benign
aroxysmal  positional  vertigo),  this  study  found  some  rela-
ions,  such  as:  the  hyperinsulinemic  patient  has  a  RR  4.6
imes  higher  for  BPPV  recurrence,  compared  with  the  gen-
ral  population  --  a  statistically  signiﬁcant  ﬁnding.  Likewise,
he  hyperglycemic  patient  has  a  RR  2.47  times  higher  for
PPV  recurrence,  also  statistically  signiﬁcant.  On  the  other
and,  patients  with  a  normal  glucose--insulin  curve  test  have
 RR  of  only  0.22,  also  statistically  signiﬁcant.  This  means
hat  having  a  normal  value  may  be  a  protective  factor  for
ecurrence  of  BPPV.
Tanimoto  et  al.24 found  that  the  only  risk  factor  for  recur-
ence  of  BPPV  was  the  presence  of  endolymphatic  hydrops.
onsidering  that  the  literature  is  pretty  consistent  regarding
he  association  between  hyperinsulinism  and  endolymphatic
ydrops,  we  can  call  into  question  whether,  in  fact,  hyperin-
ulinism  would  not  be  an  underlying  event  to  endolymphatic
ydrops  --  this  latter  being  the  actual  risk  factor  for  those
ecurrence  values  found  by  the  author  in  his  series.
Furthermore,  Tanimoto  et  al.24 reported  that  the  recur-
ence  of  benign  paroxysmal  positional  vertigo  was  associated
ith  secondary  causes,  more  than  to  idiopathic  BPPV.  This
tatement,  combined  with  the  results  of  our  study,  makes
t  possible  to  propose  the  hypothesis  of  a  form  of  BPPV
econdary  to  glucose  metabolism  disorders.
onclusion
lucose  metabolism  disorders  are  related  to  BPPV  recur-
ence  in  the  group  evaluated.  In  this  study,  we  found  that
oth  hyperinsulinism  and  hyperglycemia  behaved  as  risk  fac-
ors  for  recurrence  of  idiopathic  BPPV,  and  also  that  a  normal
lucose  tolerance  test  acted  as  a  protective  factor.
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